These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17294523)

  • 21. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
    Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. After discontinuation of calcineurin inhibitors, tapering of mycophenolate mofetil further impairs donor-directed cytotoxicity.
    van Besouw NM; van de Wetering J; van der Mast BJ; de Kuiper R; Baan CC; Weimar W
    Clin Transplant; 2008; 22(2):129-35. PubMed ID: 18339130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of donor-specific regulatory T-cell function in kidney transplant patients.
    Hendrikx TK; van Gurp EA; Sewgobind VD; Mol WM; Schoordijk W; Klepper M; Velthuis JH; Geel A; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2009 Feb; 87(3):376-83. PubMed ID: 19202442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
    Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
    Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4+FOXP3+ regulatory T cells.
    Demirkiran A; Sewgobind VD; van der Weijde J; Kok A; Baan CC; Kwekkeboom J; Tilanus HW; Metselaar HJ; van der Laan LJ
    Transplantation; 2009 Apr; 87(7):1062-8. PubMed ID: 19352129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation.
    Macedo C; Walters JT; Orkis EA; Isse K; Elinoff BD; Fedorek SP; McMichael JM; Chalasani G; Randhawa P; Demetris AJ; Zeevi A; Tan H; Shapiro R; Landsittel D; Lakkis FG; Metes D
    Transplantation; 2012 Apr; 93(8):813-21. PubMed ID: 22343334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients.
    Gerrits JH; van de Wetering J; Weimar W; van Besouw NM
    Transplantation; 2009 Mar; 87(6):907-14. PubMed ID: 19300195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells.
    Fujiki M; Esquivel CO; Martinez OM; Strober S; Uemoto S; Krams SM
    Liver Transpl; 2010 Feb; 16(2):147-54. PubMed ID: 20104482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.
    Ahsan N; Johnson C; Gonwa T; Halloran P; Stegall M; Hardy M; Metzger R; Shield C; Rocher L; Scandling J; Sorensen J; Mulloy L; Light J; Corwin C; Danovitch G; Wachs M; VanVeldhuisen P; Salm K; Tolzman D; Fitzsimmons WE
    Transplantation; 2001 Jul; 72(2):245-50. PubMed ID: 11477347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejection.
    Dijke IE; Korevaar SS; Caliskan K; Balk AH; Maat AP; Weimar W; Baan CC
    Transplantation; 2009 Apr; 87(8):1191-200. PubMed ID: 19384166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Alwayn IP; Weimar W; Hoogduijn MJ
    Transplantation; 2009 Mar; 87(6):896-906. PubMed ID: 19300194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.
    Pham PT; Pham PC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of Rapamycin on CD4(+) CD25(+) regulatory T cells in allo-transplantation tolerance model].
    Zheng YX; Hou GH; Song J; Zhang C; Liang T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Apr; 23(4):327-30. PubMed ID: 17428387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil immunosuppression in high-risk renal transplant recipients.
    Abouna GM; al Arrayed AS; Farid E; Awad CK; Sharqawi SA; Tantawi M
    Transplant Proc; 1998 Dec; 30(8):4077-8. PubMed ID: 9865302
    [No Abstract]   [Full Text] [Related]  

  • 39. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
    Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
    Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
    Zhu B; Liu Z; Wu C; Wang P; Wang X; Xu H
    Transplant Proc; 2008 Sep; 40(7):2258-61. PubMed ID: 18790207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.